The UB-developed scoring system is twice as accurate at predicting antibody resistance among U.S. children with the rare disease.

The SUNY Distinguished Professor has been named the 2022 recipient of the Retina Research Foundation’s Paul Kayser International Award in Retina Research.

A  paper published recently by UB mathematicians suggests that “hypergraphs” 
better explain how neuronal networks communicate.

The results of a UB clinical trial on the drug semaglutide turned out to be better than anything the participants — or researchers — expected.

A UB-led study found that extending the pre-quit duration of a leading smoking cessation medication doesn’t help smokers quit.

Channavix Therapeutics and Peregrine BioVentures are developing patent families related to long-lasting, non-addictive pain therapeutics.

Infectious disease expert Oscar G. Gómez-Duarte talks with UBNow about the alarming surge in these viruses among kids and what parents can do to keep them healthy.

The $15 million NSF program, based at Cornell, will foster innovation and accelerate economic development in Western New York.

The Jacobs School alumnus was the keynote speaker for the Community Health Equity Research Institute’s annual research day.

The EPA initiative aims to improve health outcomes in neighborhoods whose residents are more likely to suffer chronic, serious diseases.